Invetech Company Profile

Background

Overview

Invetech is a privately held product realization company specializing in the design, engineering, and manufacturing of fully customizable platforms tailored to clients' needs. With over 35 years of experience, Invetech has been instrumental in transforming groundbreaking ideas into market-ready solutions, particularly in the health and life sciences sectors. The company operates globally, with offices in Melbourne, Australia, and San Diego, California.

Mission and Vision

Invetech's mission is to push the boundaries of what's possible in health and life sciences by collaborating closely with clients and leveraging deep domain expertise. The company envisions revolutionizing human health through innovative product development, aiming to improve lives and advance science.

Primary Area of Focus

Invetech focuses on custom engineering solutions that power the next generation of diagnostics and cell therapies. Their services encompass instrument development, contract manufacturing, and the creation of single-use consumables, supporting innovation at every stage of product development.

Industry Significance

As a leader in product realization, Invetech has significantly contributed to the advancement of medical technology, life sciences, and cell therapy markets. Their expertise has enabled the successful commercialization of numerous diagnostic instruments and therapeutic devices, enhancing healthcare delivery worldwide.

Key Strategic Focus

Core Objectives

Invetech aims to deliver end-to-end solutions that accelerate product development timelines, reduce risks, and enhance product quality for clients in the diagnostics and cell therapy sectors. The company emphasizes a collaborative approach, integrating seamlessly with clients' teams to bring innovative products to market efficiently.

Specific Areas of Specialization

• Diagnostics and Life Sciences: Design and development of diagnostic instruments and consumables, including point-of-care diagnostics and laboratory analyzers.

• Cell Therapy Solutions: Custom automation development, ready-to-use products, and configurable platforms for cell and gene therapy manufacturing.

Key Technologies Utilized

Invetech employs a range of advanced technologies, including:

• Motion Control Systems: For precise liquid handling and positioning.

• Fluidics: Designing systems for accurate fluid management in diagnostics and cell therapy applications.

• Thermal Management: Ensuring optimal temperature control in sensitive biological processes.

• User Experience Design: Creating intuitive interfaces for medical devices and diagnostic instruments.

Primary Markets Targeted

Invetech primarily serves the following markets:

• Medical Technology: Developing devices and systems for diagnostics and therapeutic applications.

• Life Sciences: Providing solutions for research and clinical laboratories.

• Cell and Gene Therapy: Offering manufacturing solutions for advanced therapies.

Financials and Funding

Funding History

As a privately held company, Invetech has not publicly disclosed detailed financial information or funding history. In 2024, Invetech's management completed a management buyout from Fortive Corporation, marking a significant milestone in the company's financial trajectory.

Recent Funding Rounds

Specific details regarding recent funding rounds are not publicly available.

Notable Investors

Information about individual investors is not publicly disclosed.

Intended Utilization of Capital

While specific plans are not detailed, the capital from the management buyout is expected to support Invetech's strategic initiatives, including expanding capabilities in diagnostics and cell therapy markets, enhancing technological platforms, and fostering innovation.

Pipeline Development

Key Pipeline Candidates

Invetech collaborates with clients to develop a diverse range of products, including:

• Diagnostic Instruments: Point-of-care devices and laboratory analyzers.

• Cell Therapy Manufacturing Systems: Automated platforms for cell and gene therapy production.

Stages of Development

Invetech engages in all stages of product development, from concept design and prototyping to manufacturing and commercialization.

Target Conditions

The company's products address various medical conditions, including infectious diseases, cancer, and genetic disorders, by providing diagnostic solutions and therapeutic manufacturing systems.

Anticipated Milestones

Specific timelines for product milestones are typically client-specific and confidential.

Technological Platform and Innovation

Proprietary Technologies

Invetech has developed proprietary modules and subsystems that can be reused and reconfigured to enable more rapid and reliable development of diagnostic instruments.

Significant Scientific Methods

• Agile Methodologies: Applied across all diagnostics platform projects to reduce time to market and improve product reliability.

• Experience Design: A human-centered approach to design, focusing on creating the best possible interaction from the user's point of view.

AI-Driven Capabilities

In June 2025, Invetech announced a strategic collaboration with AiCella to integrate artificial intelligence into cell therapy manufacturing processes, aiming to optimize production and enhance patient outcomes.

Leadership Team

Key Executives

• Andreas Knaack: President & CEO. Andreas has been with Invetech since 2004, leading key initiatives and becoming CEO after the management buyout in 2024. He holds a degree in computer engineering from Hamburg University of Applied Sciences.

• Janet O'Meara: Chief Financial Officer. With 32 years of experience, Janet has held CFO roles across various industries, including 23 years in global organizations. She is also the head of IT at Invetech.

• Paul Bowen: Chief Legal Officer. Paul joined Invetech in 2021, bringing over 25 years of legal expertise, including nearly two decades in private practice. He earned his law degree from the University of Kansas.

• Damian Verdnik, PhD: Head of Diagnostics. With over 25 years in life sciences and healthcare, Damian holds degrees in mathematical physics and philosophy, along with a PhD in the history of quantum mechanics from Monash University.

• Sarah Phillips: Vice President, Cell Therapy. Sarah has over 20 years in healthcare, spanning diagnostics, clinical trials, and regulatory affairs. She earned a Biomedical Science degree with honors from the University of the West of England.

• Richard Badham: Vice President, Operations. Richard has over 13 years in the healthcare industry, transitioning from aviation. He worked at Rolls-Royce in the UK before moving to Australia and joining Invetech.

• Paul Tsironis: Vice President, Business Excellence. Paul leads Invetech’s Business Excellence function, leveraging his background in engineering and leadership to drive continuous improvement and innovation. He holds a Bachelor’s degree in Electrical Engineering from The University of Melbourne.

• Phillippa Martin: Vice President, People and Culture. With extensive experience in the healthcare sector, Phillippa holds both a Bachelor’s and Master’s degree in Human Resources from Monash University. She has been a key player at Invetech for over eight years.

• Ewa Douroux, PhD: Vice President, Marketing. Ewa has over 20 years of international experience in life sciences, diagnostics, and clinical research. She holds a PhD in Neural Stem Cells and an MBA.

Leadership Changes

In June 2025, Invetech announced the appointment of Neill Reynolds as Chief Financial Officer and Jason Qiu as Senior Financial Planning and Analysis Director, effective June 2, 2025.

Competitor Profile

Market Insights and Dynamics

The market for product realization services in diagnostics and cell therapy is growing, driven by advancements in medical technology and increasing demand for personalized medicine. Companies like Invetech are well-positioned to capitalize on these trends by offering comprehensive solutions that accelerate product development and commercialization.

Competitor Analysis

Invetech's main competitors include:

• Ximedica: A product development firm specializing in medical devices and diagnostics.